Silo Pharma, Inc. (SILO) stock
SILONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.71+0.14 (+8.57%)
Close on Nov 17, 2026Market cap $2.72MP/E –Yield –
Silo Pharma price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Silo Pharma's price to sales ratio was 38.4× on Nov 11, 2026, against 67.5× a year earlier. Over the last 4 years it ranged from 25.7× to 386.0×, with a median of 67.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 38.4× | −10.9 |
| 2025 | Dec 31, 2025 | 49.3× | −6.0 |
| 2024 | Dec 31, 2024 | 55.4× | +5.7 |
| 2023 | Dec 29, 2023 | 49.7× | −78.5 |
| 2021 | Oct 29, 2021 | 128.2× | −257.8 |
| 2020 | Oct 30, 2020 | 386.0× | – |
See a number that looks wrong?